Global Information
회사소개 | 문의 | 비교리스트

전자처방전(E-Prescribing) 시장 - 구성요소별(솔루션, 서비스), 전개 방식별(온프레미스, 클라우드), 최종사용자별(병원, 개업의, 제약기업) : 세계 기회 분석과 산업 예측(2019-2026년)

E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2019-2026

리서치사 Allied Market Research
발행일 2020년 02월 상품코드 936157
페이지 정보 영문 190 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 3,840 ₩ 5,455,000 Excel (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 5,769 ₩ 8,195,000 PDF (Single User License + Covid impact) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 6,450 ₩ 9,162,000 PDF (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,995 ₩ 12,778,000 PDF (Enterprise User License) help
동일 기업 내의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



전자처방전(E-Prescribing) 시장 - 구성요소별(솔루션, 서비스), 전개 방식별(온프레미스, 클라우드), 최종사용자별(병원, 개업의, 제약기업) : 세계 기회 분석과 산업 예측(2019-2026년) E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2019-2026
발행일 : 2020년 02월 페이지 정보 : 영문 190 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 전자처방전(E-Prescribing) 시장의 주요 성장요인으로서 각국 정부의 지원책과 보조금 지급, 약물 남용 및 불법 약물 예방, 의료비 절감 필요성 등을 들 수 있습니다. 특히 아시아태평양의 신흥국가에서의 보급 동향이 세계 시장 전체의 성장 촉진으로 이어지고 있습니다.

세계의 전자처방전(E-Prescribing) 시장에 대해 분석했으며, 제품 개요, 시장의 기본 구조 및 최신 동향, 주요 시장 성장 촉진요인 및 억제요인, 향후 시장 기회, 시장 규모 실적과 예측(향후 8년간), 구성요소별·전개 방식별 최종사용자별·지역별 상세 동향, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 개요

제3장 시장 개요

  • 시장의 정의와 범위
  • 전자처방전(E-Prescribing) 시장을 좌우하는 주요인
  • 밸류체인 분석
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
  • 전자처방전(E-Prescribing) : 산업 로드맵
  • 각국 정부 규제의 영향

제4장 전자처방전(E-Prescribing) 시장 : 구성요소별

  • 개요
  • 솔루션
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모와 예측 : 지역별
    • 시장 분석 : 국가별
  • 서비스

제5장 전자처방전(E-Prescribing) 시장 : 전개 방식별

  • 개요
  • 웹/클라우드 기반
  • 온프레미스(On-premise)

제6장 전자처방전(E-Prescribing) 시장 : 최종사용자별

  • 개요
  • 병원
  • 개업의
  • 제약기업

제7장 전자처방전(E-Prescribing) 시장 : 지역별

  • 개요
    • 시장 규모 및 예측 : 지역별
  • 북미
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모와 예측 : 구성요소별
    • 시장 규모와 예측 : 전개 방식별
    • 시장 규모와 예측 : 최종사용자별
    • 시장 분석 : 국가별
  • 유럽
  • 아시아태평양
  • 라틴아메리카, 중동 및 아프리카

제8장 경쟁 환경

  • 기업별 시장 포지셔닝(2018년)
  • 주요 성공 전략
  • 시장의 주요 동향
    • 신제품 출시
    • 제휴
    • 사업 확장
    • 기업 인수
    • 협업
  • 특허 분석
    • 지역별(2016-2019년)
    • 출원인별

제9장 기업 개요

  • Allscripts Healthcare, LLC
    • 기본 데이터
    • 경영진
    • 기업 개요
    • 사업 분야
    • 제품 포트폴리오
    • 연구개발(R&D) 비용
    • 실적
    • 주요 전략 전개 상황, 시장의 주요 동향
  • Athenahealth, Inc.
  • Cerner Corporation
  • Change Healthcare
  • DrFirst.com, Inc.
  • eClinicalWorks
  • Epic Systems Corporation
  • Medical Information Technology, Inc.
  • Practice Fusion, Inc.
  • Surescripts
LSH 20.06.11

LIST OF TABLES

  • TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018-2026 ($MILLION)
  • TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018-2026 ($MILLION)
  • TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 2018-2026 ($MILLION)
  • TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018-2026 ($MILLION)
  • TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018-2026 ($MILLION)
  • TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018-2026 ($MILLION)
  • TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
  • TABLE 68. PARTNERSHIP (2016-2019)
  • TABLE 69. KEY EXPANSION (2016-2019)
  • TABLE 70. KEY ACQUISITION (2016-2019)
  • TABLE 71. COLLABORATION (2016-2019)
  • TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
  • TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
  • TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
  • TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
  • TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
  • TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
  • TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
  • TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
  • TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 85. DRFIRST: KEY EXECUTIVES
  • TABLE 86. DRFIRST: COMPANY SNAPSHOT
  • TABLE 87. DRFIRST: PRODUCT PORTFOLIO
  • TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
  • TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
  • TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
  • TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
  • TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
  • TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
  • TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
  • TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
  • TABLE 100. SURESCRIPTS: KEY EXECUTIVES
  • TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
  • TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. KEY MARKET SEGMENTS
  • FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018-2026
  • FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018-2026
  • FIGURE 04. TOP IMPACTING FACTORS
  • FIGURE 05. TOP INVESTMENT POCKETS
  • FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
  • FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
  • FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
  • FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
  • FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
  • FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
  • FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
  • FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
  • FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018-2025
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018-2026 ($MILLION)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018-2026 ($MILLION)
  • FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
  • FIGURE 43. PATENT ANALYSIS, BY REGION
  • FIGURE 44. PATENT ANALYSIS, BY APPLICANT
  • FIGURE 45. R&D EXPENDITURE, 2016-2018 ($MILLION)
  • FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 49. CERNER CORPORATION: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)

Electronic prescribing or e-prescribing is a digital application that securely provides bidirectional electronic information exchange between payers/PBMs, pharmacies, prescribing providers, directly or through an intermediary network. E-prescribing includes routing prescriptions that ensures prescribed drug against the patient's health formulary of covered drugs, obtains prior authorization, gains any known patient drug allergies, identifiesany drug-drug interactions, provides access to patients' medication history from external sources, and sends or receives acknowledgement of prescriptions filled. The major capability of e-prescribing is to support important process in care delivery, such as medication management, medication reconciliation, and prior authorization, this in turn is driving the e-prescribing market growth.

Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.

The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the current & future trends of the market to elucidate the imminent investment pockets.
  • Information about key drivers, restraints, and opportunities and their impact analysis on the global e-prescribing market size is provided.
  • Porter's five forces analysis illustrates the potency of the buyers and suppliers operating in the global e-prescribing industry.
  • The quantitative analysis of the market from 2018 to 2026 is provided to determine the global e-prescribing market potential.

KEY MARKET SEGMENTS

By Component

  • Solutions
  • Services

By Deployment

  • On-premise
  • Cloud

By End User

  • Hospitals
  • Office-based Physicians
  • Pharmaceuticals

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

KEY MARKET PLAYERS

  • Allscripts Healthcare, LLC
  • Athenahealth, Inc.
  • Cerner Corporation
  • Change Healthcare
  • DrFirst.com, Inc.
  • eClinicalWorks
  • Epic Systems Corporation
  • Medical Information Technology, Inc.
  • Practice Fusion, Inc.
  • Surescripts

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. KEY MARKET PLAYERS
  • 1.5. RESEARCH METHODOLOGY
    • 1.5.1. Secondary research
    • 1.5.2. Primary research
    • 1.5.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS
    • 2.1.1. Top impacting factors
    • 2.1.2. Top investment pockets
  • 2.2. CXO PERSPECTIVE

CHAPTER 3: MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
  • 3.3. VALUE CHAIN ANALYSIS
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
      • 3.4.1.1. Government initiatives and incentive programs
      • 3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
      • 3.4.1.3. Need to curtail escalating healthcare costs
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of systems
      • 3.4.2.2. Security & workflow issues
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth in the developing countries across Asia-Pacific
  • 3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
  • 3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET

CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT

  • 4.1. OVERVIEW
  • 4.2. SOLUTIONS
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market analysis, by country
  • 4.3. SERVICES
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market analysis, by country

CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT

  • 5.1. OVERVIEW
  • 5.2. WEB & CLOUD-BASED
    • 5.2.1. Key market trends, growth factors, and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market analysis, by country
  • 5.3. ON-PREMISE
    • 5.3.1. Key market trends, growth factors, and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market analysis, by country

CHAPTER 6: E-PRESCRIBING MARKET, BY END USER

  • 6.1. OVERVIEW
  • 6.2. HOSPITALS
    • 6.2.1. Key market trends, growth factors, and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market analysis, by country
  • 6.3. OFFICE-BASED PHYSICIANS
    • 6.3.1. Key market trends, growth factors, and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market analysis, by country
  • 6.4. PHARMACEUTICALS
    • 6.4.1. Key market trends, growth factors, and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market analysis, by country

CHAPTER 7: E-PRESCRIBING MARKET, BY REGION

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast, by region
  • 7.2. NORTH AMERICA
    • 7.2.1. Key market trends, growth factors, and opportunities
    • 7.2.2. Market size and forecast, by component
    • 7.2.3. Market size and forecast, by deployment
    • 7.2.4. Market size and forecast, by end user
    • 7.2.5. Market analysis, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by component
      • 7.2.5.1.2. Market size and forecast, by deployment
      • 7.2.5.1.3. Market size and forecast, by end user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by component
      • 7.2.5.2.2. Market size and forecast, by deployment
      • 7.2.5.2.3. Market size and forecast, by end user
  • 7.3. EUROPE
    • 7.3.1. Key market trends, growth factors, and opportunities
    • 7.3.2. Market size and forecast, by component
    • 7.3.3. Market size and forecast, by deployment
    • 7.3.4. Market size and forecast, by end user
    • 7.3.5. Market analysis, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by component
      • 7.3.5.1.2. Market size and forecast, by deployment
      • 7.3.5.1.3. Market size and forecast, by end user
      • 7.3.5.2. UK
      • 7.3.5.2.1. Market size and forecast, by component
      • 7.3.5.2.2. Market size and forecast, by deployment
      • 7.3.5.2.3. Market size and forecast, by end user
      • 7.3.5.3. France
      • 7.3.5.3.1. Market size and forecast, by component
      • 7.3.5.3.2. Market size and forecast, by deployment
      • 7.3.5.3.3. Market size and forecast, by end user
      • 7.3.5.4. Rest of Europe
      • 7.3.5.4.1. Market size and forecast, by component
      • 7.3.5.4.2. Market size and forecast, by deployment
      • 7.3.5.4.3. Market size and forecast, by end user
  • 7.4. ASIA-PACIFIC
    • 7.4.1. Key market trends, growth factors, and opportunities
    • 7.4.2. Market size and forecast, by component
    • 7.4.3. Market size and forecast, by deployment
    • 7.4.4. Market size and forecast, by end user
    • 7.4.5. Market analysis, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by component
      • 7.4.5.1.2. Market size and forecast, by deployment
      • 7.4.5.1.3. Market size and forecast, by end user
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by component
      • 7.4.5.2.2. Market size and forecast, by deployment
      • 7.4.5.2.3. Market size and forecast, by end user
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by component
      • 7.4.5.3.2. Market size and forecast, by deployment
      • 7.4.5.3.3. Market size and forecast, by end user
      • 7.4.5.4. Rest of Asia-Pacific
      • 7.4.5.4.1. Market size and forecast, by component
      • 7.4.5.4.2. Market size and forecast, by deployment
      • 7.4.5.4.3. Market size and forecast, by end user
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors, and opportunities
    • 7.5.2. Market size and forecast, by component
    • 7.5.3. Market size and forecast, by deployment
    • 7.5.4. Market size and forecast, by end user
    • 7.5.5. Market analysis, by country
      • 7.5.5.1. Latin America
      • 7.5.5.1.1. Market size and forecast, by component
      • 7.5.5.1.2. Market size and forecast, by deployment
      • 7.5.5.1.3. Market size and forecast, by end user
      • 7.5.5.2. Middle East
      • 7.5.5.2.1. Market size and forecast, by component
      • 7.5.5.2.2. Market size and forecast, by deployment
      • 7.5.5.2.3. Market size and forecast, by end user
      • 7.5.5.3. Africa
      • 7.5.5.3.1. Market size and forecast, by component
      • 7.5.5.3.2. Market size and forecast, by deployment
      • 7.5.5.3.3. Market size and forecast, by end user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
  • 8.2. TOP WINNING STRATEGIES
  • 8.3. KEY DEVELOPMENTS
    • 8.3.1. Product launches
    • 8.3.2. Partnership
    • 8.3.3. Business expansion
    • 8.3.4. Acquisition
    • 8.3.5. Collaboration
  • 8.4. PATENT ANALYSIS
    • 8.4.1. By region (2016-2019)
    • 8.4.2. By applicant

CHAPTER 9: COMPANY PROFILE

  • 9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. R&D Expenditure
    • 9.1.7. Business performance
    • 9.1.8. Key strategic moves and developments
  • 9.2. ATHENAHEALTH, INC.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Product portfolio
    • 9.2.5. Key strategic moves and developments
  • 9.3. CERNER CORPORATION
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Product portfolio
    • 9.3.5. Business performance
    • 9.3.6. Key strategic moves and developments
  • 9.4. CHANGE HEALTHCARE
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Product portfolio
    • 9.4.5. Key strategic moves and developments
  • 9.5. DRFIRST
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Product portfolio
    • 9.5.5. Key strategic moves and developments
  • 9.6. ECLINICALWORKS
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Product portfolio
    • 9.6.5. Key strategic moves and developments
  • 9.7. EPIC SYSTEMS CORPORATION
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Product portfolio
    • 9.7.5. Key strategic moves and developments
  • 9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Product portfolio
    • 9.8.5. Key strategic moves and developments
  • 9.9. PRACTICE FUSION, INC.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Product portfolio
    • 9.9.5. Key strategic moves and developments
  • 9.10. SURESCRIPTS
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Product portfolio
    • 9.10.5. Key strategic moves and developments
Back to Top
전화 문의
F A Q